Video Experimental Relacionado

Updated: Nov 26, 2025

Particle Agglutination Method for Poliovirus Identification
07:06

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

15.7K

Opciones de vacuna contra el poliovirus: otro paso adelante

Kimberly M Thompson1

  • 1Kid Risk, Orlando, FL 32819, USA.

Lancet (London, England)
|December 14, 2020
PubMed
Resumen

No abstract available in PubMed .

Más Videos Relacionados

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.4K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.4K

Videos de Experimentos Relacionados

Last Updated: Nov 26, 2025

Particle Agglutination Method for Poliovirus Identification
07:06

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

15.7K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.4K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.4K

Videos de Conceptos Relacionados

Vaccinations01:51

Vaccinations

49.5K
Overview
49.5K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

685
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
685

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Collateral damage from violent incidents: human costs of polio immunization.

Bulletin of the World Health Organization·2025

Characterization of environmental and clinical surveillance inputs to support prospective integrated modeling of the polio endgame.

PLOS global public health·2025

The Health and Economic Benefits of United States Investments in Measles and Rubella Control and Elimination.

Vaccines·2024

Increasing Population Immunity Prior to Globally-Coordinated Cessation of Bivalent Oral Poliovirus Vaccine (bOPV).

Pathogens (Basel, Switzerland)·2024

Review of Poliovirus Transmission and Economic Modeling to Support Global Polio Eradication: 2020-2024.

Pathogens (Basel, Switzerland)·2024

Evolution of global polio eradication strategies: targets, vaccines, and supplemental immunization activities (SIAs).

Expert review of vaccines·2024

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Prediction-Based Family Selection in Early Stage Sugarcane Breeding: Comparing BLUP, BLUE, Phenotypic Indices, and Machine Learning.

Plants (Basel, Switzerland)·2026

Physical Instability and Functional Deterioration of High-Protein Dairy Powders: Mechanisms of Caking, Agglomeration, and Rehydration Loss.

Molecules (Basel, Switzerland)·2026

Legume breeding for intercropping is indispensable for species expected to face high competition.

Frontiers in plant science·2026

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas genome editing transforming crop stress tolerance for global food security.

PeerJ·2026

Biochar and milk vetch synergistically enhance rice yield and soil fertility via regulating N-cycling in reddish paddy fields.

Frontiers in plant science·2026

Mechanistic and scale-specific analyses advance the preference-performance hypothesis.

Ecology·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas
Jove
Visualize
Contáctanos